Caitlin Raymond: Understanding IgA Deficiency and Anaphylaxis Risk
Caitlin Raymond, a board-certified Clinical Pathologist and current Transfusion Medicine Fellow at the National Institutes of Health, shared a post on LinkedIn:
“Somewhere in a chart, someone typed IgA deficient.
No level.
No reaction history.
Just the label.
And because the label exists, every transfusion from here on is ordered as washed red cells and IgA-deficient plasma.
But do we actually know what were protecting against?
- Immunology defines selective IgA deficiency as under 7 mg/dL. Transfusion medicine uses under 0.05 mg/dL, confirmed by a send-out assay. Those are very different populations.
- Roughly 20 to 40% of IgA-deficient patients develop anti-IgA, yet donor studies show no increase in reactions in recipients of anti-IgA-containing components.
- Anti-IgA is estimated to account for only a small fraction of anaphylactic transfusion reactions.
- Canadian Blood Services recommends testing after a documented severe reaction, not as a prophylactic screen.
Our ordering habits are more conservative than the guidance.
I don’t think the evidence was ignored.
I think it never quite dispersed a caution built into practice decades ago, and nobody circled back to ask whether that caution still fits.
Next time IgA deficient shows up with no further detail, is did we wash the cells the right question?
What does your blood bank do when the label is all you have?”

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 05:47Multidisciplinary Teams Kick Off SAHF MASAC ES 2026 with Pre-Symposium Workshops – South African Haemophilia Foundation
-
Nov 17, 2026, 05:41Boitumelo Malatji: South African Delegation Advances Advocacy Strategies at NNHF Southern Africa Workshop
-
Nov 17, 2026, 05:36Joining the PACTA Uganda Mental Health and Addiction Community Camp 2026 – Tackle Sickle Cell Africa
-
Nov 17, 2026, 05:30Nathan Connell: Women’s Hematology Summit 2027 to Address Hematologic Health Across the Lifespan
-
Nov 17, 2026, 05:25Mane Kurghinyan: Representing Armenia and HemAI Dynamics at the Falling Walls Lab Global Finale 2026
-
Nov 17, 2026, 01:27X. Long Zheng: Optimizing Treatment in Immune TTP
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH